Erlotinib Completed Phase 1 Trials for Advanced Adult Primary Liver Cancer / Adult Primary Hepatocellular Carcinoma / Localized Unresectable Adult Primary Liver Cancer / Recurrent Adult Primary Liver Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00047346Erlotinib in Treating Patients With Unresectable Liver Cancer and Liver Dysfunction